Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;331:108 (9 July), doi:10.1136/bmj.331.7508.108-a
| The first 150 words of the full text of this article appear below. |
EDITORIn their prospective randomised trial of calcium and vitamin D supplementation, Porthouse et al found no evidence that this reduced the risk of clinical fractures in women at risk.1 However, several aspects need closer examination before a therapeutic role can be defined.
Although these women all had risk factors for hip factors, they were highly self selected. Of 48 987 originally invited, only 3314 (7%) were eventually randomised. Median follow-up overall was only 25 months, and the design of the recruitment process means that this must have differed between the two groups. In the "unequally allocated group," followed up for longer, the evidence of a benefit of the intervention is greater.
Vitamin D concentrations were not measured to see the prevalence of insufficiency and whether this degree of supplementation was able to produce a significant improvement in values. It would also have been informative to see whether improved
Julian R F Walters, reader in gastroenterology
Hammersmith Hospital, Imperial College, London W12 0NN julian.walters@imperial.ac.uk